Abstract

This paper offers a systematic review of advancements in electronic nose technologies for early cancer detection with a particular focus on the detection and analysis of volatile organic compounds present in biomarkers such as breath, urine, saliva, and blood. Our objective is to comprehensively explore how these biomarkers can serve as early indicators of various cancers, enhancing diagnostic precision and reducing invasiveness. A total of 120 studies published between 2018 and 2023 were examined through systematic mapping and literature review methodologies, employing the PICOS (Population, Intervention, Comparison, Outcome, and Study design) methodology to guide the analysis. Of these studies, 65.83% were ranked in Q1 journals, illustrating the scientific rigor of the included research. Our review synthesizes both technical and clinical perspectives, evaluating sensor-based devices such as gas chromatography–mass spectrometry and selected ion flow tube–mass spectrometry with reported incidences of 30 and 8 studies, respectively. Key analytical techniques including Support Vector Machine, Principal Component Analysis, and Artificial Neural Networks were identified as the most prevalent, appearing in 22, 24, and 13 studies, respectively. While substantial improvements in detection accuracy and sensitivity are noted, significant challenges persist in sensor optimization, data integration, and adaptation into clinical settings. This comprehensive analysis bridges existing research gaps and lays a foundation for the development of non-invasive diagnostic devices. By refining detection technologies and advancing clinical applications, this work has the potential to transform cancer diagnostics, offering higher precision and reduced reliance on invasive procedures. Our aim is to provide a robust knowledge base for researchers at all experience levels, presenting insights on sensor capabilities, metrics, analytical methodologies, and the transformative impact of emerging electronic nose technologies in clinical practice.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.